Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
IRON
IRON
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IRON News
Disc Medicine Shares Plunge 22% After FDA Complete Response Letter
2d ago
seekingalpha
Disc Medicine's Drug Approval Denied, Shares Plunge 21%
2d ago
stocktwits
FDA Responds to Bitopertin Application with Complete Response Letter
2d ago
Newsfilter
Pomerantz LLP Investigates Securities Fraud Claims Against Disc Medicine
Jan 27 2026
Globenewswire
Disc Medicine's Drug Approval Delayed to Feb 10, Stock Rises 2.59%
Jan 16 2026
Benzinga
FDA Delays Disc Medicine's Bitopertin Drug Review, Analysts See Minor Impact
Jan 16 2026
Newsfilter
Disc Medicine's Bitopertin Approval Delayed to February
Jan 15 2026
stocktwits
FDA Delays Review of Fast-Track Drugs Under Trump Administration, Impacting Multiple New Treatments
Jan 15 2026
Benzinga
Disc Medicine (IRON) and Sanofi (SNY) Drug Review Delays Exceed 12 Months
Jan 15 2026
seekingalpha
Disc Medicine Appoints New HR Chief to Support Commercialization Efforts
Jan 12 2026
Globenewswire
Disc Medicine Appoints Lisa Amaya Price as Chief HR Officer to Support Commercialization Efforts
Jan 12 2026
Newsfilter
Disc Medicine's Bitopertin Receives FDA Priority Review Voucher, Multiple Data Updates Expected in 2026
Jan 12 2026
Globenewswire
Disc Medicine's CLO Sells 6,500 Shares for $511,472 Amid Strong Financial Position
Jan 11 2026
NASDAQ.COM
Disc Medicine's CLO Sells 6,500 Shares for $511,472 in Derivative Transaction
Jan 11 2026
Fool
Activist Investors Target Seadrill, Vestis, Mastercraft Boat, and Other Stocks
Dec 26 2025
Barron's
Disc Medicine Reaches Oversold Status (IRON)
Dec 19 2025
NASDAQ.COM
Show More News
